Evidence map›Paper›PMID 40594969›Full record

ArticleScientific reports2025

Revealing spatiotemporal variations in areas potentially linked to COVID-19 spread using fine-grained population data.

Nobumasa Ishida, Masashi Toyoda, Kazutoshi Umemoto, Koji Zettsu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nobumasa IshidaDepartment of Information and Communication Engineering, Graduate School of Information Science and Technology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1138656, Japan. ishida@biom.t.u-tokyo.ac.jp.
Masashi ToyodaInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 1538505, Japan. toyoda@tkl.iis.u-tokyo.ac.jp.
Kazutoshi UmemotoInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 1538505, Japan.
Koji ZettsuUniversal Communication Research Institute, National Institute of Information and Communications Technology, 3-5 Hikaridai, Seika-cho, Kyoto, 6190289, Japan.

Funding

JST CREST JPMJCR19A4The National Institute of Informational and Communications Technology (NICT) No. 222, Task C
6 · The paper itself

Abstract

The COVID-19 pandemic has highlighted the need to better understand the dynamics of disease spread in cities in order to develop efficient and effective epidemiological strategies. In this study, we utilise fine-grained spatiotemporal population data obtained from mobile devices to identify areas and time of day that may contribute to COVID-19 spread, and investigate how they change throughout different waves of the pandemic. To evaluate the potential risk to city residents, we analyse the correlation between the effective reproduction number and population dynamics at locations regularly visited by these residents. Our case study of Tokyo identifies highly-correlated areas at a fine-grained level, revealing shifts in these areas within cities and across urban and suburban regions as the pandemic progresses. We also explore the characteristics of the potential areas of concern through the lenses of points of interest and population dynamics. Our findings have implications for comprehensively understanding the spatiotemporal dynamics of COVID-19 and offer insights into public health interventions for managing pandemics.

Indexed as

COVID-19CitiesHumansPandemicsPopulation DynamicsSARS-CoV-2Spatio-Temporal AnalysisTokyo

Identifiers

PMID40594969
PMCPMC12215455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.